Psychedelic drug development pipeline review, most impactful clinical trial results, foreseeable opportunities and challenges - 1) MDMA for PTSD; 2) Psilocybin for treatment-resistant depression (TRD); 3) Psilocybin, SSRIs, and brain imaging in depression